You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Refractory Acute Myelogenous Leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Risk Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston

Completed
  • High Risk Myelodysplastic Syndrome
  • +2 more
  • Daratumumab
  • Houston, Texas
    M D Anderson Cancer Center
Nov 21, 2022

Acute Myelogenous Leukemia, MDS Trial in Shanghai (Gentulizumab)

Recruiting
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndromes
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Feb 22, 2022

AML Trial in Hangzhou (MAX-40279-01)

Recruiting
  • AML
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University
Jan 18, 2022

Acute Myelogenous Leukemia in Relapse, Acute Myelogenous Leukemia, Relapsed, Adult, Acute Myelogenous Leukemia, Adult Trial in

Terminated
  • Acute Myelogenous Leukemia in Relapse
  • +4 more
  • Tucson, Arizona
  • +12 more
Aug 18, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

Suspended
  • Juvenile Myelomonocytic Leukemia
  • +27 more
  • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

Active, not recruiting
  • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 2, 2022

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Recruiting
  • Recurrent Childhood Acute Myeloid Leukemia
  • +17 more
    • Miami, Florida
      Nicklaus Children's Hospital
    May 13, 2023

    Ex Vivo Drug Sensitivity Testing and Mutation Profiling

    Completed
    • Recurrent Childhood Acute Myeloid Leukemia
    • +13 more
      • Miami, Florida
        Nicklaus Children's Hospital
      Jan 18, 2023

      Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

      Recruiting
      • Acute Biphenotypic Leukemia
      • +13 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 19, 2023

      Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded

      Not yet recruiting
      • Refractory Leukemia
      • +4 more
      • STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
      • Dendritic Cell Vaccine
      • Miami, Florida
        University of Miami
      Jan 23, 2023

      Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

      Recruiting
      • Recurrent Acute Leukemia
      • +16 more
      • Duarte, California
        City of Hope Medical Center
      Nov 22, 2022

      Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

      Not yet recruiting
      • Acute Myelogenous Leukemia
      • +17 more
      • Peripheral Blood Stem Cell Transplant
      • +7 more
      • Minneapolis, Minnesota
        Masonic Cancer Center at University of Minnesota
      Mar 27, 2023

      Acute Myeloid Leukemia, AML, Adult, Multiple Myeloma Trial in United States (FT538, Cyclophosphamide, Fludarabine)

      Recruiting
      • Acute Myeloid Leukemia
      • +3 more
      • Denver, Colorado
      • +8 more
      May 19, 2022

      Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)

      Recruiting
      • Neoplasms
      • +2 more
      • RD13-02 cell infusion
      • Xuzhou, Jiangsu, China
        Affiliated hospital of Xuzhou medical college
      Jun 7, 2023

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

      Recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +7 more
      • Blinatumomab
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 31, 2022

      Leukemia, Myeloid, Acute, Relapsed Adult AML, Refractory Leukemia Trial in Xiamen (venetoclax combining chidamide and

      Recruiting
      • Leukemia, Myeloid, Acute
      • +2 more
      • venetoclax combining chidamide and azacitidine (VCA)
      • Xiamen, Fujian, China
        Bing Xu
      Aug 1, 2022

      Myeloid Leukemia, Acute, Chronic Myeloid Leukemia, MDS Trial in Saint Petersburg (Bendamustine Hydrochloride, Cyclophosphamid)

      Recruiting
      • Myeloid Leukemia, Acute
      • +3 more
      • Saint Petersburg, Russian Federation
        RM Gorbacheva Research Institute
      Apr 4, 2022

      AML, Advanced MDS, ALL Trial in Chicago, New York (OTS167IV)

      Terminated
      • AML
      • +4 more
      • Chicago, Illinois
      • +1 more
      Nov 15, 2021

      Refractory Acute Myelogenous Leukemia, Relapsed Acute Myelogenous Leukemia Trial in Minneapolis (FATE-NK100)

      Completed
      • Refractory Acute Myelogenous Leukemia
      • Relapsed Acute Myelogenous Leukemia
      • FATE-NK100
      • Minneapolis, Minnesota
        University of Minnesota, Masonic Cancer Center
      Mar 10, 2021

      Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

      Active, not recruiting
      • Acute Myeloid Leukemia
      • +9 more
      • Los Angeles, California
      • +5 more
      Jan 27, 2023

      Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,

      Active, not recruiting
      • Acute Biphenotypic Leukemia
      • +18 more
      • Aurora, Colorado
      • +2 more
      Dec 28, 2022

      B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

      Completed
      • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Mar 25, 2022

      Acute Myelogenous Leukemia Trial in Sacramento (Bortezomib, Doxil)

      Completed
      Has Results
      • Acute Myelogenous Leukemia
      • Sacramento, California
        University of California Comprehensive Cancer Center
      Feb 4, 2021

      Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood Trial in United States (AC220, Cytarabine,

      Completed
      Has Results
      • Lymphoblastic Leukemia, Acute, Childhood
      • Myelogenous Leukemia, Acute, Childhood
      • Los Angeles, California
      • +10 more
      Mar 24, 2022